Insider Trading activities of Ziopharm Oncology Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ziopharm Oncology Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ziopharm Oncology Inc since year 2005. Table 2 shows the detailed insider transactions of Ziopharm Oncology Inc since 2005. The reporting company's ticker symbol is ZIOP. The reporting company's CIK number is 1107421.
The total value of stock buying since 2005 is $66,543,796.
The total value of stock sales since 2005 is $3,615,013.
The total value of stock option exercises since 2005 is $1,382,499.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ziopharm Oncology Inc (ZIOP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 10,710 $50,122 0 $0 20,000 $54,600
2017-06 0 $0 0 $0 60,000 $291,000
2016-11 0 $0 0 $0 15,000 $97,350
2016-04 0 $0 0 $0 45,000 $225,450
2016-03 0 $0 0 $0 15,000 $75,150
2015-11 0 $0 153,333 $1,968,795 153,333 $352,665
2015-06 0 $0 147,500 $1,449,658 80,834 $264,792
2015-02 1,440,000 $12,600,000 0 $0 0 $0
2014-01 0 $0 0 $0 268,653 $21,492
2013-10 2,857,143 $10,000,000 0 $0 0 $0
2012-11 3,636,926 $0 0 $0 0 $0
2012-01 1,923,075 $9,999,990 0 $0 0 $0
2011-08 1,351,462 $6,532,063 0 $0 0 $0
2011-05 0 $0 30,000 $196,560 0 $0
2011-02 1,910,000 $10,982,500 0 $0 0 $0
2011-01 6,063,161 $14,551,586 0 $0 0 $0
2009-12 354,000 $1,097,400 0 $0 0 $0
2009-09 378,766 $691,247 0 $0 0 $0
2007-12 3,000 $8,988 0 $0 0 $0
2007-03 6,000 $29,900 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Ziopharm Oncology Inc insiders (ZIOP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-20 Brennan Murray (Director) Option Ex 20,000 2.73 54,600
2017-11-08 Cooper Laurence James Neil (Chief Executive Officer) Buy 6,440 4.68 30,139
2017-11-08 Mauney David M Md (EVP and Chief Business Officer) Buy 4,270 4.68 19,983
2017-06-12 Brennan Murray (Director) Option Ex 15,000 4.85 72,750
2017-06-12 Cannon James Anthony (Director) Option Ex 15,000 4.85 72,750
2017-06-12 Fowler Wyche (Director) Option Ex 15,000 4.85 72,750
2017-06-12 Weiser Michael (Director) Option Ex 15,000 4.85 72,750
2016-11-25 Brennan Murray (Director) Option Ex 15,000 6.49 97,350
2016-04-21 Cannon James Anthony (Director) Option Ex 15,000 5.01 75,150
2016-04-19 Weiser Michael (Director) Option Ex 15,000 5.01 75,150
2016-04-04 Fowler Wyche (Director) Option Ex 15,000 5.01 75,150
2016-03-10 Brennan Murray (Director) Option Ex 15,000 5.01 75,150
2015-11-19 Belbel Caesar J (COO, CLO, and Secretary) Sale 153,333 12.84 1,968,795
2015-11-19 Belbel Caesar J (COO, CLO, and Secretary) Option Ex 153,333 2.30 352,665
2015-06-09 Lebel Francois (Executive Vice President R&D) Sale 50,000 10.12 505,999
2015-06-09 Lebel Francois (Executive Vice President R&D) Option Ex 50,000 4.34 217,000
2015-06-04 Brennan Murray (Director) Sale 5,837 9.55 55,743
2015-06-03 Lafond Kevin G (Vice Pres., Treasurer, & CAO) Sale 57,500 9.67 555,852
2015-06-03 Lafond Kevin G (Vice Pres., Treasurer, & CAO) Option Ex 30,834 1.55 47,792
2015-06-03 Brennan Murray (Director) Sale 34,163 9.72 332,064
2015-02-09 Intrexon Corp Buy 1,440,000 8.75 12,600,000
2014-01-06 Lewis Jonathan (CEO) Option Ex 268,653 .08 21,492
2013-10-29 Intrexon Corp Buy 2,857,143 3.50 10,000,000
2012-11-07 Intrexon Corp Buy 3,636,926 .00 0
2012-01-20 Intrexon Corp Buy 1,923,075 5.20 9,999,990
2011-08-23 Intrexon Corp Buy 38,294 4.99 191,087
2011-08-22 Intrexon Corp Buy 110,792 4.91 543,988
2011-08-19 Intrexon Corp Buy 197,376 4.91 969,116
2011-08-18 Intrexon Corp Buy 153,478 4.95 759,716
2011-08-10 Fowler Wyche Buy 5,000 5.18 25,924
2011-08-09 Intrexon Corp Buy 285,518 5.13 1,464,707
2011-08-08 Intrexon Corp Buy 444,892 4.58 2,037,605
2011-08-05 Intrexon Corp Buy 116,112 4.65 539,920
2011-05-25 Weiser Michael Sale 15,000 6.53 97,950
2011-05-09 Brennan Murray Sale 15,000 6.57 98,610
2011-02-03 Intrexon Corp Buy 1,910,000 5.75 10,982,500
2011-01-12 Intrexon Corp Buy 6,063,161 2.40 14,551,586
2009-12-09 Cannon James Anthony Buy 175,000 3.10 542,500
2009-12-09 Mcinerney Timothy Buy 50,000 3.10 155,000
2009-12-08 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Buy 129,000 3.10 399,900
2009-09-15 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Buy 328,766 1.82 599,997
2009-09-15 Mcinerney Timothy Buy 50,000 1.82 91,250
2007-12-07 Lewis Jonathan (CEO) Buy 3,000 3.00 8,988
2007-03-15 Mcinerney Timothy Buy 4,000 5.00 20,000
2007-03-12 Lewis Jonathan (CEO) Buy 2,000 4.95 9,900

Insider trading activities including stock purchases, stock sales, and option exercises of ZIOP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ziopharm Oncology Inc (symbol ZIOP, CIK number 1107421) see the Securities and Exchange Commission (SEC) website.